Diabetic kidney disease (DKD) is not only one of the main complications of diabetes, but
also the leading cause of the end-stage renal disease (ESRD). The occurrence and …

Chronic kidney disease presents a health challenge that has a complex underlying
pathophysiology, both acquired and inherited. The pharmacotherapeutic treatment options …

For the purpose of predicting clinical outcomes in patients with diabetes and chronic kidney
disease, change in albuminuria is a good candidate to be a surrogate marker for future …

Background Ophiocordyceps sinensis (OS), a medicinal fungus, has been made into OS
preparations, which are frequently used as adjunctive therapy for patients with Diabetic …

Background Diabetic kidney disease (DKD) is a common and serious complication in
patients with diabetic mellitus (DM), the risk of cardiovascular events and all-cause mortality …

Background: In China, Salvia miltiorrhiza and ligustrazine (SML) injection are widely used
as adjunctive therapy for patients with diabetic kidney disease (DKD). However, different …

Diabetes mellitus (DM) often causes chronic kidney damage despite best medical practices.
Diabetic kidney disease (DKD) arises from a complex interaction of factors within the kidney …

Hypertension and type 2 diabetes mellitus (T2DM) are important, intertwined public health
issues. People with both conditions face significantly elevated risks of cardiovascular (CV) …

Many clinical studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-
1RAs) have renoprotective properties by ameliorating albuminuria and increasing …

Purpose The effect of renin-angiotensin-aldosterone system (RAAS) inhibitors in
combination with COVID-19 and diabetes mellitus (DM) remains unknown. We assessed the …